Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Intravitreal Adalimumab in Refractory Diabetic Retinopathy, Choroidal Neovascularization or Uveitis: A Pilot Study (ADA01)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2009 by Rafic Hariri University Hospital.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
American University of Beirut Medical Center
Information provided by:
Rafic Hariri University Hospital
ClinicalTrials.gov Identifier:
NCT00855608
First received: March 2, 2009
Last updated: July 20, 2011
Last verified: September 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2013
  Estimated Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)
Publications: